Please login to the form below

Not currently logged in
Email:
Password:

sepsis

This page shows the latest sepsis news and features for those working in and with pharma, biotech and healthcare.

Takeda’s Alofisel becomes Europe’s first allogeneic stem cell therapy

Takeda’s Alofisel becomes Europe’s first allogeneic stem cell therapy

TiGenix has another adipose-derived product, Cx611, which is currently undergoing a phase I/II trial in severe sepsis.

Latest news

More from news
Approximately 4 fully matching, plus 29 partially matching documents found.

Latest Intelligence

  • Leicester NHS Trust’s staff intranet is integral to HCPs’ working day

    Clinical education is another well-used section of the intranet; while anything on infection prevention is widely viewed, for example, information on C. difficile, MRSA and sepsis.

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    One notable project involved Williams reformulating the active ingredient from a GSK mouthwash, chlorhexidine, into a gel to help prevent neonatal sepsis – thereby turning a similar consumer health product into a

  • Pharma deals in May 2015 Pharma deals in May 2015

    The option is exercisable on completion of the phase II studies in acute kidney injury related to sepsis.

  • The impending threat of antibiotic resistance The impending threat of antibiotic resistance

    Causes of death by infection in the pre-antibiotic era . Childbirth. 9 women in 1000 die in childbirth - 40% from sepsis. ... Every year 35, 000 people die from sepsis in the UK – some of these deaths are from antibiotic resistant infections.

  • Detecting and managing NS

    Campaign:Increasing awareness of neutropenic sepsis (NS). Timescale:2009 to 2010. The publication of two reports from the National Chemotherapy Advisory Group (NCAG) and the National Confidential Enquiry into Patient Outcome ... the early recognition and

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • TiGenix appoints Dr Marie Paule Richard TiGenix appoints Dr Marie Paule Richard

    In her new role Richard will be responsible for the development of several products in Europe and the US, including rheumatoid arthritis and severe sepsis candidate Cx611 and Cx601, which is

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

DNA
Why precision medicine demands precision engagement
The speed of innovation brings its own challenges, says cloud computing expert...
Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...

Infographics